Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single regulatory category. The emphasis is shifting from differentiated risk communication to a comprehensive, product‑agnostic ban on advertising, promotion, and sponsorship. 📑 Key Shifts in Policy…
The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products. 🔍 Framing & Methodology • Smoking prevalence reduction is treated as the main success metric, yet the evaluation does not convincingly isolate the TPD’s impact…
Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New Zealand highlights how differing policy approaches toward nicotine products are associated with divergent trends in smoking prevalence. Both countries have implemented strong tobacco control measures…
Ireland’s upcoming Presidency of the Council of the European Union presents a strategic opportunity to shape Europe’s public health agenda at a time of growing pressure on health systems and widening inequalities in outcomes. Recent discussions highlight a clear direction: stronger coordination, a renewed focus on prevention, and the need to address high-burden diseases through…